The interplay between the receptor tyrosine kinase c-Kit (CD117) and its ligand stem cell factor (SCF) is essential for various processes like regulation of proliferation, differentiation and survival of hematopoietic cells, germ cells and melanocytes.^[@bib1]^ It further promotes cell adhesion,^[@bib2]^ spermatogenesis,^[@bib3]^ oogenesis and folliculogenesis.^[@bib4]^ In many cell types, including B and T cells, the expression of c-kit is downregulated upon cell differentiation, suggesting a role of other growth factors like, for example, BAFF (B-cell activating factor) for B cells^[@bib5]^ or transforming growth factor-*β* (TGF-*β*) for T cells^[@bib6]^ for their development and differentiation. However, mast cells (MCs), natural killer (NK) cells, dendritic cells (DCs) and decidual macrophages retain c-Kit expression.^[@bib7]^ At the fetomaternal interface, c-Kit is highly expressed in the decidua (maternal part) as well as in the placenta (fetal part).^[@bib8],\ [@bib9]^ A point mutation in the tyrosine kinase domain of the Kit-receptor^[@bib10]^ in WBB6F~1~-W/W^v^ mice results in severe pathologic abnormalities and infertility,^[@bib11],\ [@bib12]^ whereas an inversion mutation of the *kit* gene^[@bib13]^ in *Kit*^*W-sh/W-sh*^ mice has less severe effects, with the mice being reportedly fertile.^[@bib14]^ Besides their profound deficiency in MC populations, other immune cells are not affected as *Kit*^*W-sh/W-sh*^ displayed normal levels of B cells, T cells, macrophages, DCs, peripheral NKs and basophils,^[@bib15]^ probably due to the expression of c-Kit in the hematopoietic stem cells of *Kit*^*W-sh/W-sh*^ mice.^[@bib16]^ Therefore, these mice represent a powerful tool to investigate the influence of MC deficiency, caused by a defective *c-Kit* signaling on pregnancy-relevant processes.

MCs are widely known as effector cells responsible for mediating allergic disorders and innate immunity. However, emerging evidence has identified a central role for these cells in the development and establishment of adaptive immune responses, as they are able to produce a variety of both pro- and anti-inflammatory mediators.^[@bib17]^ MCs are present in the myometrium, endometrium and cervix from humans and rodents, where they preferentially localize around blood vessels.^[@bib18],\ [@bib19],\ [@bib20],\ [@bib21],\ [@bib22]^ Little is known, however, about the functional contribution of MCs to uterine remodeling and, thus, to pregnancy establishment and the mechanisms underlying this effect. As implantation of the blastocyst into the maternal endometrium requires substantial tissue remodeling and MCs are a rich source of biologically active mediators,^[@bib17],\ [@bib23]^ we hypothesized that MCs may be important players in pregnancy establishment and maintenance.

Early morphological observations suggest an association of MCs and histamine release with ovum implantation.^[@bib24]^ The *in vivo* exposure to MC stabilizers, which inhibit their degranulation, resulted in decreased uterine endothelial cell proliferation and reduced vascular endothelial growth factor-A (VEGF-A) secretion.^[@bib21]^ In addition, we have recently shown that MCs degranulate in the uterus in response to hormone stimulation.^[@bib25]^ Pregnant women affected by systemic mastocytosis or asthma exhibit manifestations of preterm labor and delivery.^[@bib26]^ Recent studies, however, discarded a participation of MCs in the induction of labor in a mouse model.^[@bib27]^ We undertook the present study using MC-deficient *Kit*^*W-sh/W-sh*^ mice, whose MC deficiency is caused by a defective *c-Kit* gene expression, to characterize the role of MCs in pregnancy success and to dissect the mechanisms underlying the modulatory functions of these cells.

Results
=======

Uterine MC numbers increased during the fertile period of the estrous cycle
---------------------------------------------------------------------------

We first analyzed the number of uterine MCs throughout the estrous cycle and early pregnancy. MC numbers were highest during the fertile phase of the cycle, namely in estrus when the female is sexually receptive and the endometrium is prepared for nidation ([Figures 1a and b](#fig1){ref-type="fig"}). MC numbers were even higher on days 2 and 5 of gestation ([Figure 1a](#fig1){ref-type="fig"}), but declined rapidly if fecundation did not occur (metestrus). As mast cell deficiency in *Kit*^*W-sh/W-sh*^ is caused by a defective *c-Kit* signaling and *c-*Kit/*c-Kit* ligand interaction is important for oocyte development and folliculogenesis,^[@bib4]^ we monitored the estrous cycle in these mice. Sexually mature *Kit*^*W-sh/W-sh*^ showed a normal estrous cycle in respect to time duration with clearly distinguishable phases. Besides, MCs were not critical for ovulation as shown by similar number of *corpora lutea* in MC-deficient *Kit*^*W-sh/W-sh*^ and their wild-type counterparts ([Supplementary Figure 1](#sup1){ref-type="supplementary-material"}).

Uterine MCs revealed a unique phenotype and were located close to blood vessels at implantation sites
-----------------------------------------------------------------------------------------------------

We next examined the presence of MCs in allogeneic implantation sites of wild-type mice. MCs locate in between the implantation sites ([Figure 1c](#fig1){ref-type="fig"}). At midpregnancy, MCs were present in high numbers at the maternal side of the fetal--maternal interface and in general mainly localized close to blood vessels ([Figures 1d and e](#fig1){ref-type="fig"}, f, i). A detailed characterization of uterine MCs revealed that they represent a heterogeneous population containing connective tissue MCs ([Figure 1f](#fig1){ref-type="fig"} ii), mucosal MCs ([Figure 1f](#fig1){ref-type="fig"}, iii) and MCs undergoing different stages of differentiation or transdifferentiation^[@bib28]^ ([Figure 1f](#fig1){ref-type="fig"}, iv). The uterine MC population was positive for CD117 ([Figure 1f](#fig1){ref-type="fig"}, v--vi) and mast cell protease 8 (Mcpt8; [Figure 1f](#fig1){ref-type="fig"}, vii--viii, and [Supplementary Figure 2a](#sup1){ref-type="supplementary-material"}), while the percentage of uterine MCs expressing Mcpt5 oscillated between 5--20%, as shown using isolated uterine cells from *Mcpt5-Cre ROSA26 EYFP* mice (C57BL/6J background;^[@bib29]^ [Supplementary Figure 2b](#sup1){ref-type="supplementary-material"}). Thus, uterine MCs represent a heterogeneous population characterized by a distinctive phenotype.

Kit^W-sh/W-sh^, c-Kit deficient mice, present a phenotype of aberrant implantation that can be completely reverted by systemic or local transfer of wild-type MCs
-----------------------------------------------------------------------------------------------------------------------------------------------------------------

To analyze implantation, *Kit*^*W-sh/W-sh*^ females (C57BL/6J background) were mated with BALB/c males, because allogeneic matings represent natural, biologically relevant combinations compared with, for example, syngeneic ones. MC deficiency was related with significantly less implanted blastocysts compared with wild types (median=0, *n*=23 *versus* median= 9, *n*=19, *P*\<0.05; [Table 1a](#tbl1){ref-type="table"} and [Figure 2a](#fig2){ref-type="fig"}). Uteri from *Kit*^*W-sh/W-sh*^ mice were swollen and reddish with no implantations ([Figure 2a](#fig2){ref-type="fig"} iii), or contained few macroscopically normal implantations ([Figure 2a](#fig2){ref-type="fig"} iv). Implantation was also impaired in the context of a syngeneic combination ([Supplementary Table 1](#sup1){ref-type="supplementary-material"}) and litter size in *Kit*^*W-sh/W-sh*^mice was significantly reduced ([Supplementary Table 2](#sup1){ref-type="supplementary-material"}). Reconstitution of *Kit*^*W-sh/W-sh*^ mice with bone marrow-derived wild type and therefore c-Kit-expressing mast cells (BMMCs) completely restored the numbers of implantations and litter size (median: 7, *n*=17; [Table 1](#tbl1){ref-type="table"} and [Figure 2a](#fig2){ref-type="fig"}, v). Systemic MC transfer successfully reconstituted the MC compartment in lymph nodes draining the fetal--maternal unit ([Figure 2b](#fig2){ref-type="fig"}), inguinal and mesenteric lymph nodes ([Figures 2c and d](#fig2){ref-type="fig"}), and the decidua ([Figure 2e](#fig2){ref-type="fig"}). As the development of all hematopoietic stem cells is dependent on SCF, the *c-Kit* ligand, it would be possible that other immune cell populations could be affected by the defective *c-Kit* signaling in the *Kit*^*W-sh/W-sh*^ model. However, BMMC transfer did not lead to relevant changes in the frequency of T helper cells, NK cells, cytotoxic T cells or activated dendritic cells in spleen, lymph nodes, blood or decidua (data not shown), excluding the possibility that these immune cells could be responsible for the observed effects after reconstitution. This could be explained by the detected c-Kit expression in hematopoietic stem cells of *Kit*^*W-sh/W-sh*^.^[@bib16]^ Notably, uterine NKs were augmented in *Kit*^*W-sh/W-sh*^ animals compared with controls (data not shown), suggesting an interplay between these two cell types and a possible counterregulatory effect. Neutrophils were not analyzed.

As reconstitution with BMMCs normalized the peripheral and local MC compartment, we next examined whether uterine MCs are critical for implantation. We locally transferred BMMCs into one horn of the bicorneal uterus of *Kit*^*W-sh/W-sh*^ mice, whereas the other horn received buffer solution. Local transfer of MCs restored normal number of implantations at sites of MC transfer and augmented the expression of Mcpt1, Mcpt5 and Mcpt8 on mRNA levels ([Supplementary Figure 3](#sup1){ref-type="supplementary-material"} and [Supplementary Figures 4a--c](#sup1){ref-type="supplementary-material"} and [Table 2](#tbl2){ref-type="table"}). Although a significantly higher number of blastocysts were implanted in the MC-reconstituted uterine horn ([Table 2](#tbl2){ref-type="table"}), all females had at least one implantation on the mock-treated site ([Supplementary Figures 3 and 5](#sup1){ref-type="supplementary-material"}). This effect is most likely explained by the fact that these sites, which are directly adjacent to the MC-reconstituted uterus horn, also showed MCs ([Supplementary Figure 5b](#sup1){ref-type="supplementary-material"}) indicating migration of MCs within the uterus or their clonal expansion. Our findings show that *Kit*^*W-sh/W-sh*^ mice present aberrant implantation that can be completely corrected upon systemic or local transfer with BMMCs. Hence, MCs are important players in implantation.

MC transfer into c-Kit-deficient mice promoted remodeling of spiral arteries: correlation with changes in Mcpts, TGF-β1 and CtGF
--------------------------------------------------------------------------------------------------------------------------------

To gain insights into the mechanisms underlying MC modulatory activity, we further examined their effect on tissue remodeling that is manifested by the ability of blastocysts to implant. At day 5, implantations of different sizes could be observed ([Supplementary Figure 6](#sup1){ref-type="supplementary-material"}). Those few implantations that succeeded in *Kit*^*W-sh/W-sh*^ females were significantly smaller at day 5, at which implantation should be finished ([Figure 3a](#fig3){ref-type="fig"}) and their development was significantly delayed ([Figure 3b](#fig3){ref-type="fig"}). Smaller implantations reflect defective nidation or even embryos that may not further develop^[@bib30]^ and derive thus in less or no embryos at later pregnancy stages. BMMC transfer further resulted in significantly augmented size and timely development of implantations ([Figures 3c and d](#fig3){ref-type="fig"}).

Successful implantation requires both tissue remodeling and angiogenesis. These processes involve the inducible expression of several mediators including VEGF-A, matrix metalloproteinase 9 (MMP-9), plasminogen activator inhibitor 1 (PAI-1), urokinase plasminogen activator (uPA), tissue-type plasminogen activator (tPA), TGF-*β*1 and CtGF, many of them synthesized by MCs.^[@bib31]^ We found that although mRNA levels for uPA, tPA, VEGF-A, MMP-9 and PAI-1 augmented following MC transfer, this upregulated expression, however, did not account for the 'loss-of-function\' phenotype as no significant differences could be observed between wild-type and MC-deficient animals ([Supplementary Figures 7a--e](#sup1){ref-type="supplementary-material"}). This might be alternatively due to a compensation process based on the augmented number of uNK cells, which synthesize all these factors.

MC chymases are known to be effector molecules of MCs that further activate other factors involved in tissue remodeling.^[@bib32],\ [@bib33]^ mRNAs for Mcpts 1, 5 and 8, which were barely expressed in the decidua of *Kit*^*W-sh/W-sh*^ MC-deficient mice, were highly expressed following BMMC transfer ([Supplementary Figures 8a--c](#sup1){ref-type="supplementary-material"}). The mRNA expression of TGF-*β*1 and connective tissue growth factor (CtGF), both pro-angiogenic molecules relevant for tissue remodeling, was significantly diminished at the fetal--maternal interface of c-Kit-deficient mice and BMMC transfer restored these cytokine levels ([Figures 3e and f](#fig3){ref-type="fig"}). TGF-*β*1 was expressed by both MCs and trophoblasts ([Figure 3g](#fig3){ref-type="fig"} ). *In vitro*, BMMCs secrete higher amounts of TGF-*β*1 than placenta explants as measured by ELISA (data not shown). CtGF was exclusively produced by trophoblasts and MCs showed high expression of TGF-*β* receptors ([Figure 3g](#fig3){ref-type="fig"}). This suggests a regulatory loop. Of note, positive correlations between TGF-*β*1, CtGF and Mcpt8 were detected ([Supplementary Figures 9a--c](#sup1){ref-type="supplementary-material"}). Thus, MCs contribute to tissue remodeling that allows implantation and normalize the TGF-*β*/CtGF axis at the trophoblast/MC interface. Impaired implantations in c-Kit-deficient mice may result in improper placentation and fetal development.^[@bib30]^ In fact, MC-deficient mice exhibited significantly smaller placentas at day 10 of pregnancy ([Figure 4a--c](#fig4){ref-type="fig"} , quantified in [Figure 4d](#fig4){ref-type="fig"}). A more in-depth examination revealed that spiral arteries generated in the absence of MCs displayed reduced lumen diameter and a higher wall/lumen ratio compared with those of wild-type mice ([Figures 4e--g](#fig4){ref-type="fig"}; quantified in [Figures 4h and i](#fig4){ref-type="fig"}). Reconstitution with BMMCs normalized both parameters ([Figure 4h and i](#fig4){ref-type="fig"}) and resulted in increased placental surface area ([Figure 4d](#fig4){ref-type="fig"}). This observation was critical, as a narrow lumen implies a defective oxygen and nutrient transport to the fetus, which can have fatal consequences for placental and fetal development. Collectively, these data confirm that MCs normalize pregnancy in c-Kit-deficient mice by positively influencing spiral artery remodeling, placentation and, thus, fetal growth.

Galectin-1 is secreted by MCs and mediates their positive effects on placentation and fetal growth
--------------------------------------------------------------------------------------------------

To further understand the mechanisms underlying MC-associated normalization of placentation, we next focused our attention on galectin-1 (Gal-1) that has emerged as a regulator of pregnancy^[@bib34]^ and is abundant in human and mouse reproductive tracts.^[@bib35]^ Given the role of Gal-1 in trophoblast survival and syncytium formation,^[@bib36]^ we asked whether MCs secrete Gal-1 to regulate placentation. Indeed, MCs expressed Gal-1 ([Figures 5a and b](#fig5){ref-type="fig"}). Interestingly, *Lgals1* mRNA expression was reduced in decidual tissue of MC-deficient animals, which was restored following adoptive transfer of wild-type BMMCs (2^−Δct^: 23.3443 in *Kit*^*W-sh/W-sh*^ mice *versus* 2^−Δct^: 36.6948 in wild-type mice and 2^−Δct^: 55.5225 in reconstituted mice, *P*\<0.05). To examine the functional relevance of MC-derived Gal-1, we adoptively transferred *Kit*^*W-sh/W-sh*^mice with Gal-1-deficient (*Lgals1*^*−/−*^) BMMCs. The majority of the implanted embryos did not survive until day 10 of pregnancy ([Table 3a](#tbl3A){ref-type="table"}). *Kit*^*W-sh/W-sh*^ mice transferred with *Lgals1*^*−/−*^ BMMCs presented a median of 100% of fetal death compared with 18.2% observed in *Kit*^*W-sh/W-sh*^ mice transferred with wild-type BMMCs ([Table 3a](#tbl3A){ref-type="table"} and [Figures 5b and c](#fig5){ref-type="fig"}). Placentas from surviving embryos were characterized by smaller labyrinth areas and unusual big areas of giant cells (GCs, [Figure 5d](#fig5){ref-type="fig"}). GCs showed abnormalities including several vacuoles in their cytoplasm ([Supplementary Figure 10](#sup1){ref-type="supplementary-material"}). *In vivo*, an incomplete reconstitution with MCs in the uterus and the draining lymph nodes was observed if *Lgals1*^*−/−*^ BMMCs were transferred ([Supplementary Figure 11](#sup1){ref-type="supplementary-material"}). In addition, Gal-1 deficiency in MCs led to decreased expansion of these cells in the presence of trophoblast cells *in vitro* ([Supplementary Figure 12](#sup1){ref-type="supplementary-material"}). This strongly suggests a defective proliferation of MCs in the uterus and/or incomplete migration of MCs to the uterus if they lack Gal-1.

Lgals1^−/−^ mice presented shallow spiral artery remodeling and altered placentation that could be rescued by the transfer of wild-type MCs
-------------------------------------------------------------------------------------------------------------------------------------------

Spiral arteries from *Lgals1*^*−/−*^ females were characterized by increased wall/lumen ratio ([Supplementary Figure 13a](#sup1){ref-type="supplementary-material"}), wall thickness ([Supplementary Figure 13b](#sup1){ref-type="supplementary-material"}) and lumen diameter ([Supplementary Figure 13c](#sup1){ref-type="supplementary-material"}), which pointed to abnormal vessel function. *Lgals1*^*−/−*^ mice had smaller implantation sizes at day 5 of pregnancy, which were comparable to those observed in *Kit*^*W-sh/W-sh*^ mice ([Supplementary Figure 14](#sup1){ref-type="supplementary-material"}). The importance of MCs secreting Gal-1 in supporting pregnancy and fetal growth was underlined by the fact that the adoptive transfer of BMMCs from wild-type animals into *Lgals1*^*−/−*^mice provoked a statistically significant reduction in the abortion rate from 18.8 to 0% (*P*=0.0014; [Table 3b](#tbl3B){ref-type="table"} and [Figure 5e](#fig5){ref-type="fig"}). Thus, MC-derived Gal-1 may serve to promote expansion of these cells in an autocrine or paracrine manner and to sustain trophoblast survival, placentation and successful pregnancy.

Discussion
==========

Adoptive transfer experiments in *Kit*^*W-sh/W-sh*^ revealed central roles of MCs in implantation and fetal survival by mediating spiral artery formation and placentation, both critical events that ensure optimal fetal development.

MCs are present in the female reproductive tract,^[@bib19],\ [@bib21],\ [@bib22]^ yet the function of these cells in reproductive biology is uncertain. In pregnant rats, MC degranulation has positive effects on cervical angiogenesis.^[@bib20]^ Menzies *et al.*^[@bib27]^ recently reported no role for these cells in labor in a syngeneic context. Yet, the involvement of these cells during early pregnancy and in a biologically relevant allogeneic context has not been studied. We found that a transient population of uterine MCs appears in cycles and as a unique population composed of connective tissue-type MCs, mucosal MCs and a transitional population that share features of both phenotypes. The number of uterine MCs peaks at the fertile phase of the estrous cycle and remaining high if pregnancy establishes.

MCs are abundant in the uterus during early pregnancy. This appears to be regulated through endocrine mechanisms, which is not surprising as they express estrogen and progesterone receptors.^[@bib37]^ We recently found that estradiol and progesterone promote MC migration from the periphery to the uterus.^[@bib25]^ To investigate the role of MCs in pregnancy, we used C57BL/6J-*Kit*^*W-sh/W-sh*^ mice. Although MC deficiency in this particular model is caused by a defective *c-Kit* signaling that could further influence other signaling pathways, this model is well established and highly accepted. Although *Kit*^*W-sh/W-sh*^ mice were described as fertile,^[@bib12]^ the maintenance of their colonies is difficult because of irregular birth rates and high natal and postnatal death rates. Allogeneically mated *Kit*^*W-sh/W-sh*^ mice show severely impaired implantation, although single mice may present normal litter size that account for their ability to breed. These single mice appear to carry their fetuses to term, an observation already made by Menzies *et al.*^[@bib27]^ in a syngeneic context. The transfer of wild-type BMMCs could completely rescue the impaired reproductive phenotype. We demonstrate that MCs are present at the fetal--maternal interface after systemic and local reconstitution, suggesting that MCs act locally to foster normal pregnancy. Recently, c-Kit-independent models have been described, including a model that relies on the expression of Mcpt5 by MCs.^[@bib38]^ Notably, we found that only 5--20% of uterine MCs express Mcpt5, suggesting that 80% of MCs would not be depleted following diphtheria toxin administration. These results would also preclude using recently generated *α*-chymase-Cre transgenic mice (Chm/Cre) whose Cre expression correlates to resident mucosal, but not to connective tissue-type MCs.^[@bib39]^ In general, the generation of novel mouse models, whose MC deficiency is independent of a c-*Kit*-mutation,^[@bib38],\ [@bib40]^ offer new insights in MC biology, but their relevance for different systems must be individually examined.

MC chymases Mcpt1, Mcpt5 and Mcpt8 were present at high levels in *Kit*^*W-sh/W-sh*^ mice after systemic and local transfer. As chymases contribute to matrix degradation, tissue remodeling and angiogenesis,^[@bib31]^ a new concept emerges, which implies MCs as essential initiators of tissue remodeling during pregnancy. We show that MC deficiency results in severely impaired implantation followed by defective spiral artery remodeling, effects that are restored by MC reconstitution. Analysis of c-Kit-deficient uteri during implantation revealed blastocysts at different implantation stages. Measurement of the attached blastocysts revealed smaller sizes and a delayed kinetic than the wild types. These results are worthwhile to be discussed in terms of the fatal impact of delayed implantation in pregnancy outcome.^[@bib30]^ Interestingly, reconstituted *Kit*^*W-sh/W-sh*^ mice presented normal implantation numbers and sizes. This clearly shows that the aberrant implantation phenotype of c-Kit-deficient mice relies on the fact that they lack MCs.

The phenotype of *Kit*^*W-sh/W-sh*^ mice may be attributable to the activation of MC proteases that stimulate other mediators involved in tissue remodeling and/or angiogenesis; these include tPA, uPA, PAI-1, VEGF-A, MMP9, tryptase and chymase.^[@bib17],\ [@bib31],\ [@bib41],\ [@bib42]^ Systemic and local MC reconstitution of *Kit*^*W-sh/W-sh*^ mice led to increased uterine expression of several molecules, for example, uPA and tPA, both related to implantation.^[@bib41]^ In line with this evidence, mice lacking uPA and tPA suffer from extensive fibrin deposition with impaired organ function, loss of fertility and reduced survival.^[@bib43]^ PAI-1, known to have an essential role in tissue remodeling,^[@bib44]^ was also augmented following MC reconstitution. Interestingly, PAI-deficient mice presented similar placental morphology like *Lgals*-1^−/−^ mice.^[@bib44]^ In this context, MC proteases may be more relevant as c-Kit-deficient mice have comparable PAI-1, uPA, tPA, VEGF-A and MMP-9 levels but significantly less Mcpts than wild types. We found that MCs are involved in the interplay between CtGF and TGF-*β*1. CtGF has been implicated in matrix production during the menstrual cycle, uterine cell growth,^[@bib45]^ implantation, development and differentiation of the embryo,^[@bib46]^ extracellular matrix (ECM) synthesis and angiogenesis.^[@bib47]^ TGF-*β*1 mRNA was described in mouse tissues including placenta and developing mouse fetus.^[@bib48]^ TGF-*β*-null mice develop a multiorgan autoimmune inflammatory disease leading to organ failure and rapid death after birth.^[@bib49]^ In our system, trophoblasts and MCs were sources of TGF-*β*1 whereas its receptor was highly expressed in MCs. We speculate that, as a consequence of a dysregulated TGF-*β*1/CtGF axis, thicker spiral artery walls are generated, leading to narrow lumen and inadequate fetus supply. In our model, these abnormalities were prevented upon reconstitution with wild-type BMMCs. Importantly, although lethality of mice lacking TGF-*β*1 or CtGF precludes the possibility of analyzing the pathophysiologic relevance of these molecules in the context of MC deficiency, a strong positive correlation among MC-derived Mcpts, TGF-*β*1 and CtGF could be confirmed.

The glycan-binding protein Gal-1 regulates multiple events associated with successful pregnancy, including trophoblast growth, syncytium formation and angiogenesis.^[@bib35],\ [@bib36],\ [@bib37]^ We confirmed here that MCs produce and secrete Gal-1. To the best of our knowledge, this is the first report implying MCs as a major source of Gal-1. Decidual tissue obtained from MC-deficient animals showed lower expression of Gal-1 that was restored after BMMC reconstitution. *In vivo*, adoptive transfer of *Kit*^*W-sh/W-sh*^ animals with *Lgals1*^*−/−*^ BMMCs resulted in incomplete reconstitution of the uterus with MCs. Thus, Gal-1 is important for the expansion of MCs in the uterus as also suggested by our *in vitro* experiments or for their migration to the fetomaternal interface. Transfer of *Lgals1*^−/−^ BMMCs resulted in higher number of fetal death as compared with mice reconstituted with wild-type BMMCs, confirming the critical role of Gal-1 secreted by MCs. Placentas from surviving embryos derived from *Kit*^*W-sh/W-sh*^ mice transferred with *Lgals1*^*−/−*^ MCs showed altered placentation. Gal-1, secreted by MCs, substantially contributed to placentation and pregnancy success. Similar to *Kit*^*W-sh/W-sh*^ mice, spiral arteries from *Lgals1*^*−/−*^ mothers were insufficiently remodeled, supporting the critical role of Gal-1 as a mediator of MC protective function. This was confirmed by experiments in which pregnant *Lgals1*^*−/−*^ mice were transferred with Gal-1-expressing BMMC, which completely abrogated fetal death. Our data clearly show that Gal-1 secreted by MCs contributes to normal placentation through nonimmunological mechanisms.

Our data demonstrate that MCs play central roles in pregnancy by allowing tissue remodeling during implantation and/or by positively influencing placentation and fetal growth. These findings may help to delineate cellular mechanisms that govern successful pregnancies with potential applications to other biomedical fields.

Materials and Methods
=====================

Animals
-------

To investigate the possible role of MCs *in vivo* in mouse pregnancy, we used MC-deficient C57BL/6J-*Kit*^*W-sh/W-sh*^ mice. *W-sash* (*W*^*sh*^) is an inversion mutation in the transcriptional regulatory elements upstream of the *c-kit* transcription start site on mouse chromosome 5.^[@bib13]^ *W*^*sh*^ mutation results in very few developmental abnormalities, and until very recently the only reported phenotypic abnormalities in *Kit*^*W-sh/W-sh*^ mice were an impairment of skin pigmentation and a MC deficiency in the skin and peritoneal cavity.^[@bib50]^ However, MC deficiency after the age of 10 weeks becomes more profound with abnormalities reported in multiple anatomical sites.^[@bib50]^ In all the experiments reported here, we used animals older than 10 weeks to assure MC deficiency.

The present study was authorized by the German Ministry and carried out according to institutional guidelines of Berlin and Magdeburg (LaGeSo, Berlin, Germany, Reg. no. 0070/03; 203.h-42502-2-868 Magdeburg) and the Guide for the Care and Use of Agricultural Animals in Agricultural Research and Teaching, USA. BALB/c male mice were purchased from Charles River (Sulzfeld, Germany). C57BL/6J-*Kit*^*W-sh/W-sh*^ MC-deficient females were obtained from Jackson Laboratories (Bar Harbor, ME, USA). Wild-type counterparts C57BL/6J were purchased from Charles River. *Lgals1*^*−/−*^ mice were provided by Dr. F Poirier (Jacques Monod Institute, Paris, France) and bred at the Animal Facilities of the Medical Faculty, Otto-von-Guericke University (Magdeburg, Germany). Animals were maintained in our barrier animal facility with a 12-h light/dark cycle. All females were checked daily for vaginal plugs. The day at which the vaginal plug was detected was considered as day 0 of pregnancy and the females were separated from the males. The BALB/c-mated *Kit*^*W-sh/W-sh*^, BL/6 and *Lgals1*^*−/−*^ BMMC-reconstituted *Kit*^*W-sh/W-sh*^, *Lgals1*^*−/−*^ and control C57BL/6J females were killed on days 5, 6 or 10 of pregnancy or for the local reconstitution between days 10 and 12 of pregnancy, and the uteri were removed and the implantation sites were documented.

The determination of the estrous cycle in virgin C57/BL6 females was performed by vaginal lavage with 0.9% sodium chloride. The stage of the cycle was defined based on the typical cell content of the lavage. Females were killed when they showed a clear stage. To confirm the stage, samples were stained with hematoxylin/eosin and analyzed under light microscopy. The state of the cycle was defined based on the characteristic cell content in the fresh lavage (Axiovert 40C, Carl Zeiss, Jena, Germany; magnification × 200) and stained (Axio Observer.A1, Carl Zeiss; magnification × 200).

Isolation, culture and adoptive transfer of BMMCs
-------------------------------------------------

Bone marrow cells were collected from femurs and tibias of wild-type C57BL/6J or *Lgals1*^*−/−*^ females and cultured in IMDM (Iscove\'s modified Dulbecco\'s medium) supplemented with 10% fetal bovine serum (FBS), 1% penicillin/streptomycin and 30 ng/ml murine recombinant IL-3 (final, Invitrogen, Carlsbad, CA, USA) or 10 ng/ml WEHI-3-derived IL-3 for at least 5 weeks, at which time \>95% of the cells were identified as BMMCs by flow cytometric analysis of CD117^+^Fc*ɛ*RI*α*^+^ cells ([Supplementary Figure 15](#sup1){ref-type="supplementary-material"}).

For systemic MC reconstitution studies, BMMCs were transferred into 10-week-old *Kit*^*W-sh/W-sh*^ females by i.v. injection of 5 × 10^6^ cells in 200 *μ*l of PBS in the morning of two consecutive days (in total 1 × 10^7^ cells) through the tail vein. For local reconstitution, 1 × 10^6^ BMMCs were injected into different sections of the right uterine horn of *Kit*^*W-sh/W-sh*^ females, whereas the left uterine horn served as control and was mock-treated. At 12 weeks after systemic and 5 weeks after local transfer (reported time required for biological and physiological reconstitution), BMMC-reconstituted *Kit*^*W-sh/W-sh*^ females were allogenically mated with BALB/c males. Simultaneously, age-matched MC-deficient *Kit*^*W-sh/W-sh*^ and control C57BL/6J females were mated with BALB/c males.

Sample collection
-----------------

On day 10 of pregnancy, one implantation site per female was collected for cryosections and one implantation site was collected for paraffin studies with previous fixation in 4% (w/v) PFA with 0.1 M sucrose (pH 7.4) for 6 h. The uterine horns were opened longitudinally and the fetal--placental unit carefully separated from the decidua. For flow cytometry analysis, decidual samples were cut in small pieces and collected in Hanks\' balanced salt solution containing no Ca^2+^ or Mg^2+^ (Sigma, Taufkirchen, Germany). For RNA isolation or cell extract preparation for western blot analysis, tissues from placenta, decidua, spleen, thymus and lymph nodes (inguinal, axillary, mesenteric and iliac) were carefully washed with cold sterile PBS, pH 7.40, snap-frozen, and kept at −80 °C until use. When analyzing uteri from day 5 or 6 of pregnancy, females were injected i.v. with Chicago Blue dye a few minutes before killing the animal, and uterine horns were dissected and fixed in 96% (v/v) ethanol.

Flow cytometry
--------------

Tissues from decidua, spleen, thymus and lymph nodes (inguinal, axillary, mesenteric and iliac) were processed as described^[@bib51]^ and stained with the following antibodies: FITC-conjugated anti-mouse Fc*ɛ*RI*α*, PE-conjugated anti-mouse CD117, PE-conjugated rat anti-mouse I-A/I-E (MHCII), PerCP-Cy5.5-conjugated rat anti-mouse CD4, PE-Cy5-conjugated rat anti-mouse CD8a, APC-conjugated hamster anti-mouse CD11c, FITC-conjugated hamster anti-rat CD49b (which also reacts with mouse CD49b), FITC-conjugated Mcpt8 and Alexa Fluor 647-conjugated anti-mouse Foxp3. All antibodies were purchased from Becton Dickinson (BD, Heidelberg, Germany). The Fc*ɛ*RI*α* antibody was from eBioscience (Kranenburg, Germany). For Mcpt8 staining a Biolegend (Fell, Germany) antibody was combined with a FITC-conjugated goat anti-rat, cells were permeabilized and the first antibody was incubated for 30 min, followed by 30 min of the second antibody. For all analyses, the percentage of positive cells was referred to the leukocytes, unless otherwise stated. Cells stained with isotype controls (all from BD) as well as unstained cells served as controls.

Real-time reverse transcriptase-PCR (RT-qPCR)
---------------------------------------------

For real-time quantitative RT-PCR, total RNA was isolated from decidua, placenta and lymph nodes (inguinal, axillary, mesenteric, iliac). The tissue was treated with Trizol (Gibco, Life Technologies, Darmstadt, Germany) and disaggregated using a homogenator (Ultra Turrax T8; Ika, Staufen, Germany). The RNA was extracted with chloroform, precipitated with absolute ethanol, washed, and finally diluted in RNase-free water. The quantity and quality of the RNA was determined by ultraviolet absorbance at 260 nm. Total RNA (2 *μ*g) was initially incubated with oligo dTs (Amersham Pharmacia, Freiburg, Germany) for 10 min at 75 °C followed by 5 min of incubation on ice. Subtracted mRNA was then incubated with dNTPs (2.5 mmol/l; Amersham Pharmacia), DNase I (2 U/ml, Stratagene, Waldbronn, Germany) and RNase inhibitor (40 U/ml, Promega, Mannheim, Germany) in a reaction buffer. The mix was incubated for 30 min at 37 °C and further heated at 75 °C for 5 min. The addition of the RT (200 U/ml, Promega) and RNase inhibitor in diethyl pyrocarbonate water (diethyl pyrocarbonate was from Sigma) started the reverse transcription. This reaction mixture was incubated at 42 °C for 60 min, followed by incubation at 94 °C for 5 min. Amplification reactions were performed in 13 *μ*l of final reaction volume of SYBR Green Master Mix (Applied Biosystems, Darmstadt, Germany) as follows: initial denaturation at 95 °C for 5 min, followed by 40 cycles of denaturation step at 95 °C for 45 s and annealing step at either 56 °C or 60 °C for 60 s. All samples were normalized to the *β*-actin transcript levels. All reactions were carried out on an iCycler (Bio-Rad, Munich, Germany). Primer sequences are available upon request.

Western blot analysis
---------------------

Protein extraction from tissue and cells was performed on ice. Tissue or cells were incubated in lysis buffer (10% NP-40, 0.1 mg/ml n-Dodecil-*β*-𝒟-maltoside, 500 mℳ sodium fluoride, 10 mℳ sodium metavanadate, 100 mℳ PMSF, 1 M Tris, 0.5 M EDTA and 5 M NaCl) for 60 min. After sonication, cells were centrifuged and supernatants were collected. After overnight storage at −80 °C, protein content was determined by Bradford assay (Bio-Rad) as indicated by the manufacturers. Then, 50 *μ*g of proteins were resolved on a 15% SDS-PAGE at 80 V for 4 h and transferred onto a 0.2 *μ*m nitrocellulose membrane in transfer buffer containing 20% (v/v) methanol, 0.19 M glycine and 0.025 M Tris (pH 8.3) at a constant voltage (80 V) for 2 h on ice. After blocking nonspecific-binding sites with 5% (w/v) skim milk powder in TBS with 0.05% (v/v) Tween for 1 h, blots were incubated overnight at 4 °C using the following antibodies: TGF-*β*1 (V, 1 : 200, Santa Cruz, Heidelberg, Germany), CtGF (L-20, 1 : 100, Santa Cruz), TGF-*β* RII (C-16, 1 : 200, Santa Cruz), Gal-1 (1 : 400) (kindly provided by Dr. GA Rabinovich, Ref. 61) and for 2 h at room temperature using *β*-actin (AC-15, 1 : 10 000, Sigma-Aldrich, St. Louis, MO, USA), respectively.

Histopathology and immunohistochemistry
---------------------------------------

Uteri and whole implantation sites were dissected and fixed in either 96% (v/v) ethanol or 4% (v/v) PFA with 0.1 M sucrose, pH 7.4. After dehydration in ethanol, tissue samples were embedded in paraffin. Sections of 5 *μ*m thickness were stained with hematoxylin/eosin for analysis of morphology and Toluidine blue dye (0.1% aqueous solution or 0.5% in 0.5 N 5 N HCl overnight) for visualizing MCs in the myometrium by the metachromatic staining of secretory granules. The number of MCs was analyzed within the myometrium and calculated per 1 mm^2^ by using an Eyepiece-micrometer (Zeiss). To distinguish between mucosal and connective tissue-type MCs, the uterine tissue was stained first with Alcian blue (1% in 3% acetic acid) followed by Safranin (0.5% in 0.125 N HCl). For Mcpt8 staining, slides were boiled in citrate buffer and endogenous peroxidase and protein were blocked. The slides were incubated ON at 4 °C with anti-Mcpt8 (BioLegend) antibody followed by incubation with the secondary antibody goat anti-rat (Jackson Immuno Research, West Grove, PA, USA) for 1 h at RT. Counterstaining was done using hematoxylin.

DBA lectin reacts specifically with uterine NKs on all gestational days and at all stages of differentiation. To identify and quantify the number of uterine NKs, the DBA-lectin staining was done as described elsewhere.^[@bib52]^ Tissue samples for cryosections (whole implantation sites) were embedded in cryo-medium and cut into 5 *μ*m sections. After air-drying, sections were stained with Toluidine blue dye (0.5% in 0.5 N HCl) for identification of MCs. Immunofluorescence for CD117 was performed using a primary antibody from Cedarlane Lab (Burlington, ON, Canada) and FITC-labeled goat anti-rat (Invitrogen) as secondary antibody.

Quantitative histological measurements
--------------------------------------

The quantitative measurements of the implantation sites as well as placentas were done as described elsewhere^[@bib52]^ by using the software AxioVision4 (Zeiss). Shortly, H/E-stained sections were used to measure the surface area of both the implantation sites on gestation days 5 and 6 as well as the size of the placenta (both in *μ*m^2^) at a × 200 magnification. To best characterize the size of the placenta at day 10, we cut 10 serial sections from the central part of each implantation site. This section, which contains the largest placental area, was chosen for the analysis. Then, upon having this clearly defined area we proceeded to determine the surface area as described in Croy *et al.*^[@bib52]^ This method allows the best possible characterization of the placenta size due to the technical impossibility of dissecting this tissue from the rest at day 10 of pregnancy. The quantitative measurements of the spiral arteries was performed as described elsewhere.^[@bib52]^ Briefly, the spiral artery wall and lumen diameters were measured by using the software AxioVision (Zeiss) and/or expressed as wall/lumen ratios and wall thickness.

Co-culture experiments
----------------------

The murine trophoblast cell line SM9-2 was propagated in culture in RPMI-1640 with 20% FBS and 1% penicillin/streptomycin, 1 mM sodium pyruvate, 5 × 10^−5^ M 2-mercapthoethanol, incubated at 37 °C in a humidified atmosphere of 5% CO~2~. PKH26-stained SM9-2 cells were co-cultured with CFDA-SE-stained BMMCs for 48 h and the proliferation of trophoblasts was measured using flow cytometry.

Data analysis and statistics
----------------------------

Data were analyzed using GraphPad Prism5 (Witzenhausen, Germany), expressed as means or medians depending on their distribution (normal or not normal). For data regarding MC quantification, flow cytometry, PCR and *in vivo* data after BMMC reconstitution, differences among all groups were calculated by the Kruskall--Wallis test and the difference between two independent groups was calculated using the Mann--Whitney *U-*test. To analyze differences in the implantation numbers in the half of the uterus transferred with BMMCs or with vehicle, the Wilcoxon test was applied. For histological analysis of implantation size at day 5 as well as histological measurements, 1 to 6 implantations and 2 to 10 spiral arteries per female were measured by AxioVision4 (Zeiss), the mean for each specimen was calculated, and the differences between the animal groups analyzed using unpaired *t*-test. For all tests, *P-*value of \<0.05 was considered to be statistically significant. The number of samples or animals, the statistical test used and the *P-*values obtained are indicated in each figure or table legend.
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![The numbers of uterine MCs increase during the fertile period of the estrus cycle and remain high during early gestation. Female virgin C57BL/6J females were checked for their phase of the estrous cycle. (**b**i--iv) Characteristic pictures from hematoxylin/eosin (H/E)-stained vaginal lavage samples of each phase are shown. (**b**v--viii) The number of MCs in uterine paraffin sections (5 *μ*m) of female virgin (*n*= 4--7), 2-day and 5-day pregnant BALB/c-mated C57BL/6J females (gd2 and gd5, *n*=5 each) was quantified in 1 mm^2^ (magnification × 200) areas by visualizing them with Toluidine blue O staining (0.1%). The mean MC number from both the right and left uterine horn was calculated and included in (**a**). At day 5 of pregnancy, MCs were located in between the implantation sites (**c**), whereas at day 10 of pregnancy, MCs were detected in the decidua, the maternal part of the fetomaternal interface, of BALB/c-mated C57BL/6J females (**d**) and are particularly localized close to blood vessels (e; magnification × 1000). (**f**) Uterine MCs that are positive for Toluidine blue (i), Safranin (ii), Alcian blue (iii) and double positive for Safranin and Alcian blue (iv). In the lower panel, uterine MCs are shown that are positive for CD117 (v and vi) or Mcpt-8 (vii and viii). i--iv and vi: magnification × 1000, v and vii: × 100 magnification and viii: × 400 magnification. Arrows indicate uterine MCs. Data are expressed as single dots with medians and were analyzed by using the Mann--Whitney *U-*test (\**P*\<0.05; \*\**P*\<0.01; \*\*\**P*\<0.001)](cddis2012214f1){#fig1}

![Systemic transfer of BMMCs reverses the low number of implantations of MC-deficient mice. *Kit*^*W-sh/W-sh*^ females (W-sh) were reconstituted systemically with BMMCs 12 weeks before being mated with BALB/c males. Implantation success was documented on day 10 of pregnancy. BALB/c-mated C57BL/6J females and *Kit*^*W-sh/W-sh*^ females served as controls. In (**a**) representative pictures are shown from uteri of (i) a virgin C57BL/6J female, (ii) a normal pregnant C57BL/6J, (iii) a non-pregnant *Kit*^*W-sh/W-sh*^ female with an inflamed and thickened uterus after successful mating, (iv) a pregnant *Kit*^*W-sh/W-sh*^ female presenting only three implantations and (v) a pregnant *Kit*^*W-sh/W-sh*^ female that was systemically reconstituted with BMMCs from wild-type mice showing 11 implantations. (**b**--**d**) Percentage of CD117/FcɛRIα^+^ cells in para-aortic (**b**), inguinal (**c**) and mesenteric (**d**) lymph nodes from C57BL/6J (*n*=7); *Kit*^*W-sh/W-sh*^ (*n*=5) or *Kit*^*W-sh/W-sh*^+BMMCs (*n*=6--7) animals. (**e**) Percentage of CD117/FcɛRIα^+^ cells in the decidua from C57BL/6J (*n*=6), *Kit*^*W-sh/W-sh*^ (*n*=5) and *Kit*^*W-sh/W-sh*^+BMMCs (*n*=5) animals. Data are expressed as medians. \**P*\<0.05, \*\**P*\<0.005, \*\*\**P*\<0.001 as analyzed by Kruskall--Wallis test followed by Mann--Whitney *U*test between two particular groups](cddis2012214f2){#fig2}

![Implantation areas of *Kit^W-sh/W-sh^* (W-sh) females are significantly smaller than those of wild-type mice and this can be reversed by transfer of BMMCs; Normalization of the TGF-*β*/CtGF axis. (**a**) Representative images of implantations as recorded at gestation days (gd) 5 and 6 in wild-type C57/BL6 and *Kit^W-sh/W-sh^* mice after Chicago Blue dye injection. The quantification of the area size (*μ*m^2^) was done by AxioVision4 (Zeiss) and is shown in (**b**) the number of mice per group was as follows: C57/BL6 day 5: *n*=9 and day 6: *n*=4, *Kit^W-sh/W-sh^* day 5: *n*=6 and day 6 *n*=4. (**c** and **d**) representative uteri (**c**) and the measured implantation areas (**d**) at day 5 as observed after Chicago Blue dye injection in C57BL/6J (*n*=9), *Kit^W-sh/W-sh^* (*n*=10) and *Kit^W-sh/W-sh^* mice previously reconstituted with wt-BMMCs (systemically) (*n*=5) Data are expressed as means. Statistical significances were analyzed by unpaired *t*-test. \**P*\<0.05, \*\* *P*\<0.005, \*\*\* *P*\<0.001. Expression of CtGF (**e**) and TGF-*β*1 (**f**) mRNA in decidual tissue of female C57BL/6J (*n*=9--11), not reconstituted Kit^W-sh/W-sh^ (W-sh; *n*=7) and systemically reconstituted *Kit^W-sh/W-sh^* (*n*=13) mice. BMMC reconstitution leads to upregulated expression of both genes to levels comparable to those observed in C57BL/6J mice. Data are expressed as median and statistical significances were analyzed by Kruskall--Wallis followed by Mann--Whitney *U*-test. \**P*\<0.05 and \*\* *P*\<0.01. (**g**) Expression of TGF-*β*1, CtGF, TGF-*β*RII and *β*-actin (served as house keeping gene) in murine trophoblast cells (SM9-2), trophoblast tissue from day 10 pregnant C57BL/6J female and wild-type BMMCs was analyzed by western blot](cddis2012214f3){#fig3}

![Mast cell deficiency results in suboptimal spiral artery remodeling and decreased placenta size: prevention by systemic BMMC transfer. Representative images of transversal cross-sections of implantation sites from C57BL/6J (**a**; *n*=7), *Kit^W-sh/W-sh^* (W-sh; **b**; *n*=5) and with wt-BMMCs systemically reconstituted *Kit^W-sh/W-sh^* (**c**; *n*=5), all pregnant at day 10. Here, the placental surface area was measured and is shown as area in *μ*m^2^ (**d**). (e--g) Spiral arteries from C57BL/6J (**a**; *n*=8), *Kit^W-sh/W-sh^* (**b**; *n*=5) and systemically reconstituted *Kit^W-sh/W-sh^* (**c**; *n*=5) of the decidua basalis in histological sections stained with H/E and quantified by AxioVision4 (Zeiss). The lumen diameter (**h**) and wall thickness of 2--10 spiral arteries/female were measured, the wall/lumen ratio was calculated and the mean was included in panel (**i**). The absence of MCs leads to an impaired spiral artery formation together with a decreased placenta size that could be corrected by a systemic reconstitution with BMMCs. Data are expressed as means. Statistical significances were analyzed by unpaired *t*-test. \**P*\<0.05 and \*\**P*\<0.01](cddis2012214f4){#fig4}

![Critical role of Gal-1 in MC-dependent regulation of fetal death. (**a** and **b**) Expression of Gal-1 at the protein level (western blot analysis as shown in **a** and immunohistochemistry ( × 1000 magnification) as in **b**) in BMMCs generated from virgin C57BL/6J females (wt-BMMC). BMMCs were additionally generated from virgin Lgals1^−/−^ females and injected systemically into *Kit^W-sh/W-sh^* females (*n*=4). On day 10 of pregnancy, the number of dead fetuses was documented (arrows in d) and presented in (**c**) together with the total number of dead fetuses of female C57BL/6J (*n*=8), *Kit^W-sh/W-sh^*, *Kit^W-sh/W-sh^* (*n*=5), *Kit^W-sh/W-sh^* systemically reconstituted with wt-BMMC (*n*=7) and Lgals1^−/−^ BMMC (*n*=6) as well as Lgals1^−/−^ (*n*=10). BMMCs express Gal-1 and the number of dead fetuses was significantly higher in KitW-sh/W-sh females receiving Lgals1^−/−^ BMMCs. Data are expressed as median and statistical significances were analyzed by Kruskall--Wallis followed by Mann--Whitney *U-*test. \**P*\<0.05, \*\**P*\<0.005. (**e**) Representative images of the giant cell zone in histological, H/E stained sections on day 10 of pregnancy are shown from C57BL/6J (i), *Kit^W-sh/W-sh^* (ii), *Kit^W-sh/W-sh^* systemically reconstituted with wt-BMMC (iii), Lgals1^−/−^ (iv) and *Kit^W-sh/W-sh^* mice systemically reconstituted with Lgals1^−/−^ BMMC (v) (magnification × 200). The comparison between giant cells with a normal (vi) and an abnormal (vii) morphology is presented with × 400 magnification. (**f**) Representative pictures of C57BL/6J (i), Lgals1^−/−^ (ii) and Lgals1^−/−^ reconstituted with BMMC. Notably, adoptive transfer of Lgals1^−/−^ mice with wt-BMMCs normalized the abortion rate](cddis2012214f5){#fig5}

###### Number of implantations per animal and percentage of pregnant mice after detection of a definite vaginal plug (C57BL/6, *Kit* ^*W-sh/W-sh*^+PBS and *Kit* ^*W-sh/W-sh*^ reconstituted with BMMC) after allogeneic mating with BALB/c males (data of implantations/animals are given as median in parentheses)

                                                  **Implantations/animals (mean; median)**   **Pregnant/plugged (%)**    ***P*****-value**
  ----------------------------------------------- ------------------------------------------ -------------------------- -------------------
  \(a\) C57BL/6J                                  144/19 (7.6; 9)                            84.2                                 
  \(b\) *Kit*^*W-sh/W-sh*^+PBS                    81/23 (3.5; 0)                             47.8                           0.02 to (a)
  \(c\) *Kit*^*W-sh/W-sh*^+BMMCs (systemically)   113/17 (6.6; 7)                            76.5                           0.05 to (b)

Statistical significances were calculated by Kruskall--Wallis test followed by Mann--Whitney *U-*test among two particular groups and are shown in the right column of the table

###### Number of implantations per animal in non-reconstituted (NR) and local reconstituted (R) uterine horns in *Kit* ^*W-sh/W-sh*^ with BMMCs after allogeneic mating with BALB/c males

                       **Implantations/animals (NR, median)**   **Implantations/animals (*****R*****, median)**
  -------------------- ---------------------------------------- -------------------------------------------------
  *Kit*^*W-sh/W-sh*^   18/10 (1)                                37/10 (4)\*

\**P*\<0.05 *versus* values for implantations/animal in the non-reconstituted uterine horn (data of implantations/animals are given as median in parentheses) analyzed by the Mann--Whitney *U-*test

###### Number of implantations per females as well as mean and median of abortion rate after detection of a definite vaginal plug (C57BL/6, *^KitW-sh/W-sh^*+PBS, reconstituted *Kit^W-sh/W-sh^* with BMMCs generated from C57BL/6J and reconstituted *Kit^W-sh/W-sh^* with BMMCs generated from *Lgals1* ^−/−^) after allogeneic mating with BALB/c males on day 10 of pregnancy (data of implantations/females are given as mean and median in parentheses)

                                                 **Implantations/females (mean; median)**    **Mean; median of fetal death \[%\]**                 ***P*****-value**
  ---------------------------------------------- ------------------------------------------ --------------------------------------- -----------------------------------------------
  *(a) C57BL/6J+PBS*                             144/19 (7.6; 9)                                            5.4; 0                                          
  *(b) Kit*^*W-sh/W-sh*^*+PBS*                   81/24 (3.4; 0)                                            22.3; 4.1                                  0.02 to (a)
  *(c) Kit*^*W-sh/W-sh*^*+C57BL/6J-BMMC*         59/9 (6.6; 7)                                            28.3; 18.2                                \<0.005 to (b)
  *(d) Lgals1*^*−/−*^                            72/10 (7.2; 9.5)                                         26.1; 18.8                                 \<0.05 to (b)
  *(e) Kit*^*W-sh/W-sh*^*+Lgals1*^*−/−*^*BMMC*   35/6 (5.8; 5.5)                                           81.7; 100                 \<0.01 to (b) \<0.05 to (c, d) \<0.005 to (a)

Percentage of fetal death is expressed as mean and median. Statistical significances were calculated by Kruskall--Wallis test followed by Mann--Whitney *U-*test among two particular groups

###### Number of implantations per females as well as mean and median of abortion rate after detection of a definite vaginal plug (C57BL/6, *Lgals1* ^−/−^ and *Lgals1* ^−/−^ reconstituted with BMMCs generated from C57BL/6J after allogeneic mating with BALB/c males on day 10 of pregnancy (data of implantations/females are given as mean and median in parentheses)

                                      **Implantations/females (mean; median)**   **Mean; median of abortion rate \[%\]**   ***P-*****value**
  ----------------------------------- ------------------------------------------ ----------------------------------------- -------------------
  \(a\) C57BL/6J                      73/10 (7.3; 9)                             7.6; 0                                     
  \(b\) *Lgals1*^−/−^                 72/10 (7.2; 9.5)                           26.1; 18.8                                0.06 to (a)
  \(c\) *Lgals1*^−/−^+C57BL/6J-BMMC   68/11 (6.2; 9)                             1.3; 0                                    0.0014 to (b)

Percentage of fetal death is expressed as mean and median. Statistical significances were calculated by Kruskall--Wallis test followed by Mann--Whitney *U-*test among two particular groups
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